Company Profile - Veracyte Inc

Introduction

Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier as an assay to evaluate patients with lung nodules that are suspected of cancer. Veracyte offers genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

Company info

Country (HQ): United States
Sector: Medical Equipment
Market Cap (US$ m): 1,815
Revenue (US$ m): 297 (2022)

Innovation ranking

450

Innovation score

Closest peers in the Medical Equipment sector

Innovation Ranking

Company
Headquarters
Sector

Medtronic Plc

Ireland

Medical Equipment

Boston Scientific Corp

United States

Medical Equipment

Veracyte Inc

United States

Medical Equipment

Savara Inc

United States

Medical Equipment

Aethlon Medical Inc

United States

Medical Equipment

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers